Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
2 offices
Technology Company

We have observed 39 EP applications Amanda Rachel Gladwin has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after April 24, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11776738

POLYMORPHS AND SALTS OF 6-(1H-INDOL-4-YL)-4-(5- { [4-(1-METHYLETHYL)-1-PI PERAZINYL]METHYL} -1,3-OXAZOL-2-YL)-1H-INDAZOLE AS PI3K INHIBITORS FOR USE IN THE TREATMENT OF E.G. RESPIRATORY DISORDERS

IPC classification:
A61K 31/422, A61P 11/00, A61P 31/12, A61P 35/00, A61P 37/00, C07D 413/14
Applicant:
Glaxo Group Limited
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12715280

THIOAMIDE, AMIDOXIME AND AMIDRAZONE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/496, A61P 31/18, C07D 209/18, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
PATENT GRANTED
EP12814906

AZAINDOLE COMPOUNDS AND METHODS FOR TREATING HIV

IPC classification:
A01N 43/42, A61K 31/44
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
PATENT GRANTED
EP12740119

COMPOSITION

IPC classification:
A61K 9/00, A61K 31/522, A61P 11/06, A61P 37/08
Applicant:
GlaxoSmithKline LLC
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP12766361

SPIRO BICYCLIC DIAMINE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/437, A61P 31/18, C07D 519/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
PATENT GRANTED
EP12766362

FUSED BICYCLIC DIAMINE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/437, A61P 31/18, C07D 519/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Annabel Rose Beacham, Dehns Ltd
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
PATENT GRANTED
EP12833476

PYRROLOPYRIDINONE COMPOUNDS AND METHODS FOR TREATING HIV

IPC classification:
A01N 43/90
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
PATENT GRANTED
EP12809969

CO-PROCESSING METHOD AND FORMULATION FOR HIV ATTACHMENT INHIBITOR PRODRUG COMPOUND AND EXCIPIENTS

IPC classification:
A61K 9/14, A61K 9/20
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13705076

METHODS FOR THE PREPARATION OF HIV ATTACHMENT INHIBITOR PIPERAZINE PRODRUG COMPOUND

IPC classification:
C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
The patent has been granted
EP12806889

VOLTAGE-GATED SODIUM CHANNEL BLOCKERS

IPC classification:
A61K 31/497, A61P 11/14, C07D 401/14, C07D 405/14
Applicant:
Glaxo Group Limited
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13744796

COMPOUNDS AND METHODS FOR TREATING HIV

IPC classification:
A61K 31/437, A61P 31/18, C07D 471/04, C07D 471/08, C07D 471/14, C07D 491/10
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
The patent has been granted
EP13756249

PYRAZOLOPYRIMIDINE COMPOUNDS

IPC classification:
A61K 31/519, A61P 37/00, C07D 487/04
Applicant:
GlaxoSmithKline LLC
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
The patent has been granted
EP13748452

PIPERIDINE AMIDE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/437, A61K 31/454, A61P 31/18, C07D 401/06, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13753225

TRICYCLIC AMIDINE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/551, A61K 31/553, A61P 31/18, C07D 403/12, C07D 413/12, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP13748451

TRICYCLIC ALKENE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/437, A61K 31/454, A61K 31/4545, A61P 31/18, C07D 401/06, C07D 401/14, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Agent:
Regina Vögeli-Lange, Swords Laboratories
Status:
PATENT GRANTED
EP14194866

OXAZOLE SUBSTITUTED INDAZOLES AS PI3-KINASE INHIBITORS

IPC classification:
A61K 31/497, A61K 31/535, A61P 11/00, A61P 31/12, A61P 35/00, A61P 37/00, C07D 413/14
Applicant:
Glaxo Group Limited
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP13857477

NOVEL COMPOUNDS

IPC classification:
A61K 31/519
Applicant:
GlaxoSmithKline LLC
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
The patent has been granted
EP13856110

NOVEL COMPOUNDS

IPC classification:
A61K 31/519
Applicant:
GlaxoSmithKline LLC
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
PATENT GRANTED
EP13857520

NOVEL COMPOUNDS

IPC classification:
A61K 31/519
Applicant:
GlaxoSmithKline LLC
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
The patent has been granted
EP15164931

ANTIVIRAL THERAPY

IPC classification:
A61K 31/4985, A61K 31/513, A61K 31/52, A61K 31/536, A61P 31/18
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP15180409

COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES

IPC classification:
A61K 31/427, A61K 31/4402, A61K 31/472, A61K 31/4725, A61K 31/496, A61K 31/506, A61P 31/18, C07D 471/04, C07D 487/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
The patent has been granted
EP14722482

2-KETO AMIDE DERIVATIVES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/404, C07D 401/06, C07D 471/04, C07D 519/00
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP15170143

PURINE DERIVATIVES FOR USE IN THE TREATMENT OF ALLERGIC, INFLAMMATORY AND INFECTIOUS DISEASES

IPC classification:
A61K 31/522, A61P 35/00, A61P 37/00, C07D 473/16, C07D 473/18
Applicant:
GlaxoSmithKline LLC
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP11785122

INHIBITORS OF HIV REPLICATION

IPC classification:
A61K 31/4365, A61K 31/506, A61K 45/06, C07D 495/04, C07D 495/14
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
PATENT GRANTED
EP11796876

ALKYL AMIDES AS HIV ATTACHMENT INHIBITORS

IPC classification:
A61K 31/437, A61P 31/18, C07D 471/04
Applicant:
Bristol-Myers Squibb Company
Agent:
Reitstötter Kinzebach & Partner GbR
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11755311

POLYMORPHS AND SALTS OF N-[5-[4-(5-{[(2R,6S)-2,6-DIMETHYL-4-MORPHOLINYL]METHYL}-& xA;1,3-OXAZOL-2-YL)-1H-INDAZOL-6-YL]-2-(METHYLOXY)-3-PYRIDINYL]METHANESULFONAMIDE

IPC classification:
A61K 31/422, A61P 11/00, C07D 413/14
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14790034

PI3K INHIBITOR FOR TREATMENT OF RESPIRATORY DISEASE

IPC classification:
A61K 31/497, A61K 31/553, A61P 11/00
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP14790537

PI3K INHIBITOR FOR TREATMENT OF RESPIRATORY DISEASE

IPC classification:
A61K 31/497, A61K 31/553, A61P 11/00
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
GRANT OF PATENT INTENDED
EP11755310

INDAZOLE DERIVATIVES FOR USE IN THE TREATMENT OF INFLUENZA VIRUS INFECTION

IPC classification:
A61K 31/416, A61K 31/422, A61K 31/4245, A61K 31/427, A61K 31/437, A61K 31/4439, A61K 31/454, A61K 31/496, A61K 31/5377, A61K 31/5386, A61P 31/16
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
PATENT GRANTED
EP13156120

Quinoline derivatives as PI3 kinase inhibitors

IPC classification:
A61K 31/47, C07D 285/24, C07D 401/04, C07D 401/14, C07D 413/14, C07D 417/14, C07D 471/04, C07D 487/04, C07D 495/04, C07D 498/04
Applicant:
GlaxoSmithKline
Applicant:
GlaxoSmithKline LLC
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11814690

PROCESS FOR PREPARING COMPOUND HAVING HIV INTEGRASE INHIBITORY ACTIVITY

IPC classification:
C07D 211/94, C07D 213/80, C07D 498/14
Applicant:
Shionogi & Co. Limited (Shionogi Seiyaku Kabushiki-gaisha)
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
PATENT GRANTED
EP15706413

PYRROLO[3,2]PYRIMIDINE DERIVATIVES AS INDUCERS OF HUMAN INTERFERON

IPC classification:
A61K 31/519, A61P 29/00, A61P 35/00, A61P 37/00, C07D 487/04
Applicant:
GlaxoSmithkline Intellectual Property (No. 2) Limited
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
The patent has been granted
EP16187411

ANTIVIRAL THERAPY

IPC classification:
A61K 31/52, A61K 31/5365, A61P 31/18
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
EXAMINATION IN PROGRESS
EP15742106

ISOINDOLINE DERIVATIVES FOR USE IN THE TREATMENT OF A VIRAL INFECTION

IPC classification:
A61K 31/4035, A61K 31/454, C07D 209/44, C07D 401/06, C07D 407/06, C07D 407/10
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15741368

ISOINDOLINONE DERIVATIVES USEFUL AS ANTIVIRAL AGENTS

IPC classification:
A61K 31/4035, A61P 31/18, C07D 209/46, C07D 405/04, C07D 413/04
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15741363

PHENYL AND TERTBUTYLACETIC ACID SUBSTITUTED PYRIDINONES HAVING ANTI-HIV EFFECTS

IPC classification:
A61K 31/4418, A61K 31/4439, A61P 31/18, C07D 213/64, C07D 213/75, C07D 213/81
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
EXAMINATION REQUESTED
EP15770489

TREATMENT OF RESPIRATORY CONDITIONS WITH NOTCH INHIBITORS

IPC classification:
A61K 31/00, A61K 31/5513, A61K 39/395
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
Request for examination was made
EP15820021

A PROCESS FOR PREPARING HALOGENATED AZAINDOLE COMPOUNDS USING BOROXINE

IPC classification:
A61K 31/437, A61P 31/18, C07D 471/04, C07F 9/09
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
Request for examination was made
EP16700303

PHARMACEUTICAL COMBINATION

IPC classification:
A61K 9/00, A61K 31/4709, A61K 31/58, A61P 11/08
Applicant:
GlaxoSmithKline Intellectual Property Development Limited
Agent:
Amanda Rachel Gladwin, GlaxoSmithKline
Status:
Request for examination was made

Please Sign in to use this feature